investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Role of p21 Activated Kinase in Leukemogenesis

Reuben Kapur

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Xin Wang

Dana-Farber Cancer Institute

Boston, United States

University of Manchester

Manchester, United Kingdom

Related projects

Ronald Hoffman

A New Murine Model for MPN: Pathology and Therapy of NF-E2 Overexpression

Leukaemia

Hematology and hematologic malignancies

David A Fruman

TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance

Leukaemia

Hematology and hematologic malignancies

Susan L Slager

Genetic Epidemiology Of Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Katy Rezvani

Curative Cell-based Therapies for Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Thomas J O'Hare

Mechanisms of Resistance to Ponatinib Therapy in Chronic Myeloid Leukemia

Leukaemia

Hematology and hematologic malignancies

James C Paulson

In vivo Targeting of Hematopoetic Cells With Glycan Ligands of Siglecs

Leukaemia

Hematology and hematologic malignancies

Robert G Roeder

Transcriptional Regulatory Mechanisms in B Cell Development and Leukemogenesis

Leukaemia

Hematology and hematologic malignancies

Alan Rein

Retrovirus Assembly and Maturation – Rockville

Leukaemia

Hematology and hematologic malignancies

Peter Aplan

Collaborative Pathways that Lead to Leukemia – Rockville

Leukaemia

Hematology and hematologic malignancies